Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

NCT01404364 is registered in ClinicalTrials.gov with Hospital Governador Celso Ramos as lead sponsor.

NCT NCT01404364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01404364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye
Lead sponsor
Hospital Governador Celso Ramos
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2010
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blind painful eye, control of pain through drug injection, refractory glaucoma